Home › Compare › CRBKF vs GBDC

CRBKF vs GBDC: Dividend Comparison 2026

CRBKF yields 7142.86% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRBKF wins by $2020155342665710.50M in total portfolio value
10 years
CRBKF
CRBKF
● Live price
7142.86%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2020155342665731.25M
Annual income
$1,966,011,161,323,515,200,000.00
Full CRBKF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — CRBKF vs GBDC

📍 CRBKF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRBKFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRBKF + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CRBKF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRBKF
Annual income on $10K today (after 15% tax)
$607,142.86/yr
After 10yr DRIP, annual income (after tax)
$1,671,109,487,124,987,800,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, CRBKF beats the other by $1,671,109,487,124,974,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRBKF + GBDC for your $10,000?

CRBKF: 50%GBDC: 50%
100% GBDC50/50100% CRBKF
Portfolio after 10yr
$1010077671332876.00M
Annual income
$983,005,580,661,765,800,000.00/yr
Blended yield
97.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CRBKF
No analyst data
Altman Z
-8.8
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRBKF buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRBKFGBDC
Forward yield7142.86% ✓11.85%
Annual dividend / share$2.00 ✓$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1% ✓
Portfolio after 10y$2020155342665731.25M ✓$20.78M
Annual income after 10y$1,966,011,161,323,515,200,000.00 ✓$16,389,263.41
Total dividends collected$2016528271361529.00M ✓$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CRBKF vs GBDC ($10,000, DRIP)

YearCRBKF PortfolioCRBKF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$724,986$714,285.71$12,490$1,790.28+$712.5K → CRBKF
2$49,172,645$48,396,910.17$16,522$3,157.73+$49.16M → CRBKF
3$3,120,421,331$3,067,806,600.72$23,578$5,898.68+$3120.40M → CRBKF
4$185,281,229,916$181,942,379,091.82$37,115$11,886.75+$185281.19M → CRBKF
5$10,294,691,143,508$10,096,440,227,497.77$66,136$26,423.57+$10294691.08M → CRBKF
6$535,299,070,050,255$524,283,750,526,701.75$137,257$66,491.44+$535299069.91M → CRBKF
7$26,050,796,629,539,330$25,478,026,624,585,550.00$341,734$194,868.54+$26050796629.20M → CRBKF
8$1,186,669,129,317,434,600$1,158,794,776,923,827,700.00$1,050,788$685,133.02+$1186669129316.38M → CRBKF
9$50,602,038,637,584,920,000$49,332,302,669,215,270,000.00$4,099,314$2,974,971.01+$50602038637580.82M → CRBKF
10$2,020,155,342,665,731,300,000$1,966,011,161,323,515,200,000.00$20,775,530$16,389,263.41+$2020155342665710.50M → CRBKF

CRBKF vs GBDC: Complete Analysis 2026

CRBKF — Stock

Carebook Technologies Inc., digital health company, provides digital health and virtual care solutions for pharmacies, employers, and insurers. The company offers pharmacy engagement platform. It also offers Wellness Checkpoint platform. The company is headquartered in Montreal, Canada.

Full CRBKF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CRBKF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRBKF vs SCHDCRBKF vs JEPICRBKF vs OCRBKF vs KOCRBKF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.